Cardiometabolic effects of two coffee blends differing in content for major constituents in overweight adults: a randomized controlled trial

European Journal of Nutrition

Volumn 54, Issue 5, 2015, Pages 845-854

  Kempf, Kerstin ^a   Kolb, Hubert ^a   Gärtner, Babette ^a   Bytof, Gerhard ^b   Stiebitz, Herbert ^b   Lantz, Ingo ^b   Lang, Roman ^c   Hofmann, Thomas ^c   Martin, Stephan ^a  

^a Dusseldorf Catholic Hospital Group   (Germany)

^b TCHIBO GMBH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coffee; Coffee and body weight; Coffee and health; N methylpyridinium

Indexed keywords

ADIPONECTIN; ALKALOID; C REACTIVE PROTEIN; CAFFEOYLQUINIC ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N METHYLPYRIDINIUM; OSTEOPONTIN; TRIACYLGLYCEROL; TRIGONELLINE; UNCLASSIFIED DRUG; 1-METHYLPYRIDINIUM; COFFEE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; PYRIDINIUM DERIVATIVE; QUINIC ACID;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHEMISTRY; DIET RESTRICTION; DRUG EFFECTS; METABOLISM; PROSPECTIVE STUDY; STATISTICAL MODEL; YOUNG ADULT;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; ALKALOIDS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR SYSTEM; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COFFEE; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LINEAR MODELS; MALE; MIDDLE AGED; OSTEOPONTIN; OVERWEIGHT; PROSPECTIVE STUDIES; PYRIDINIUM COMPOUNDS; QUINIC ACID; WAIST CIRCUMFERENCE; WEIGHT LOSS; YOUNG ADULT;

EID: 84937395961     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-014-0763-3     Document Type: Article

References (48)

1. Greenberg JA, Boozer CN, Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84:682–693
2. Natella F, Scaccini C (2012) Role of coffee in modulation of diabetes risk. Nutr Rev 70:207–217
3. Muley A, Muley P, Shah M (2012) Coffee to reduce risk of type 2 diabetes? A systematic review. Curr Diabetes Rev 8:162–168
4. Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB (2013) Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr 97:155–166
5. Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, Yannakoulia M (2013) Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. Obesity (Silver Spring) 21:1127–1132
6. Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29:1121–1129
7. Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB (2006) Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83:674–680
8. Onakpoya I, Terry R, Ernst E (2011) The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Gastroenterol Res Pract 2011:1–6
9. Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, Tuomilehto J (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91:950–957
10. Wedick NM, Brennan AM, Sun Q, Hu FB, Mantzoros CS, van Dam RM (2011) Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J 10:93
11. Ohnaka K, Ikeda M, Maki T, Okada T, Shimazoe T, Adachi M, Nomura M, Takayanagi R, Kono S (2012) Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab 2012:207426
12. Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jequier E (1980) Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 33:989–997
13. Ratnayake WM, Hollywood R, O’Grady E, Stavric B (1993) Lipid content and composition of coffee brews prepared by different methods. Food Chem Toxicol 31:263–269
14. Watanabe T, Arai Y, Mitsui Y, Kusaura T, Okawa W, Kajihara Y, Saito I (2006) The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension. Clin Exp Hypertens 28:439–449
15. Smrke S, Opitz SE, Vovk I, Yeretzian C (2013) How does roasting affect the antioxidants of a coffee brew? Exploring the antioxidant capacity of coffee via on-line antioxidant assays coupled with size exclusion chromatography. Food Funct 4:1082–1092
16. Perrone D, Donangelo R, Donangelo CM, Farah A (2010) Modeling weight loss and chlorogenic acids content in coffee during roasting. J Agric Food Chem 58:12238–12243
17. Bakuradze T, Boehm N, Janzowski C, Lang R, Hofmann T, Stockis JP, Albert FW, Stiebitz H, Bytof G, Lantz I, Baum M, Eisenbrand G (2011) Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: results from an intervention study. Mol Nutr Food Res 55:793–797
18. Boettler U, Volz N, Pahlke G, Teller N, Kotyczka C, Somoza V, Stiebitz H, Bytof G, Lantz I, Lang R, Hofmann T, Marko D (2011) Coffees rich in chlorogenic acid or N-methylpyridinium induce chemopreventive phase II-enzymes via the Nrf2/ARE pathway in vitro and in vivo. Mol Nutr Food Res 55:798–802
19. Boettler U, Sommerfeld K, Volz N, Pahlke G, Teller N, Somoza V, Lang R, Hofmann T, Marko D (2011) Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J Nutr Biochem 22:426–440
20. Kotyczka C, Boettler U, Lang R, Stiebitz H, Bytof G, Lantz I, Hofmann T, Marko D, Somoza V (2011) Dark roast coffee is more effective than light roast coffee in reducing body weight, and in restoring red blood cell vitamin E and glutathione concentrations in healthy volunteers. Mol Nutr Food Res 55:1582–1586
21. Grundy SM (2012) Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 59:635–643
22. Speer K, Kölling-Speer I (2006) The lipid fraction of the coffee bean. Braz J Plant Physiol 18:2010–2016
23. Weiss C, Rubach M, Lang R, Seebach E, Blumberg S, Frank O, Hofmann T, Somoza V (2010) Measurement of the intracellular ph in human stomach cells: a novel approach to evaluate the gastric acid secretory potential of coffee beverages. J Agric Food Chem 58:1976–1985
24. Lang, R, Wahl, A, Stark, T, Hofmann, T (2012) Identification of urinary and salivary biomarkers for coffee consumption. Recent advantages in the analysis of foods and flavors ACS symposium series
25. Lang R, Wahl A, Stark T, Hofmann T (2011) Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Mol Nutr Food Res 55:1613–1623
26. Lang R, Wahl A, Skurk T, Yagar EF, Schmiech L, Eggers R, Hauner H, Hofmann T (2010) Development of a hydrophilic liquid interaction chromatography-high-performance liquid chromatography-tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee consumption. Anal Chem 82:1486–1497
27. Gavrieli A, Yannakoulia M, Fragopoulou E, Margaritopoulos D, Chamberland JP, Kaisari P, Kavouras SA, Mantzoros CS (2011) Caffeinated coffee does not acutely affect energy intake, appetite, or inflammation but prevents serum cortisol concentrations from falling in healthy men. J Nutr 141:703–707
28. Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, Yannakoulia M (2013) Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. Obesity (Silver Spring) 21:1127–1132
29. Volz N, Boettler U, Winkler S, Teller N, Schwarz C, Bakuradze T, Eisenbrand G, Haupt L, Griffiths LR, Stiebitz H, Bytof G, Lantz I, Lang R, Hofmann T, Somoza V, Marko D (2012) Effect of coffee combining green coffee bean constituents with typical roasting products on the Nrf2/ARE pathway in vitro and in vivo. J Agric Food Chem 60:9631–9641
30. Boettler U, Volz N, Teller N, Haupt LM, Bakuradze T, Eisenbrand G, Bytof G, Lantz I, Griffiths LR, Marko D (2012) Induction of antioxidative Nrf2 gene transcription by coffee in humans: depending on genotype? Mol Biol Rep 39:7155–7162
31. Moisey LL, Robinson LE, Graham TE (2010) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 103:833–841
32. Krebs JD, Parry-Strong A, Weatherall M, Carroll RW, Downie M (2012) A cross-over study of the acute effects of espresso coffee on glucose tolerance and insulin sensitivity in people with type 2 diabetes mellitus. Metabolism 61:1231–1237
33. Cai L, Ma D, Zhang Y, Liu Z, Wang P (2012) The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 66:872–877
34. Boekschoten MV, van Cruchten ST, Kosmeijer-Schuil TG, Katan MB (2006) Negligible amounts of cholesterol-raising diterpenes in coffee made with coffee pads in comparison with unfiltered coffee. Ned Tijdschr Geneeskd 150:2873–2875
35. Correa TA, Rogero MM, Mioto BM, Tarasoutchi D, Tuda VL, Cesar LA, Torres EA (2013) Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition 29:977–981
36. Mesas AE, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E (2011) The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr 94:1113–1126
37. Rebello SA, van Dam RM (2013) Coffee consumption and cardiovascular health: getting to the heart of the matter. Curr Cardiol Rep 15:403
38. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R (2012) Association of coffee drinking with total and cause-specific mortality. N Engl J Med 366:1891–1904
39. Liu, J, Sui, X, Lavie, CJ, Hebert, JR, Earnest, CP, Zhang, J, Blair, SN (2013) Association of coffee consumption with all-cause and cardiovascular disease mortality. In: Mayo clinic proceedings
40. Larsson SC, Orsini N (2011) Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 174:993–1001
41. O’Keefe JH, Bhatti SK, Patil HR, Dinicolantonio JJ, Lucan SC, Lavie CJ (2013) Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 62:1043–1051
42. Mubarak A, Bondonno CP, Liu AH, Considine MJ, Rich L, Mas E, Croft KD, Hodgson JM (2012) Acute effects of chlorogenic acid on nitric oxide status, endothelial function, and blood pressure in healthy volunteers: a randomized trial. J Agric Food Chem 60:9130–9136
43. Chikama A, Yamaguchi T, Ochiai R, Kataoka K, Tokimitsu I (2008) Effects of hydroxyhydroquinone-reduced coffee on blood pressure in high-normotensives and mild hypertensives. J Health Sci 54:162–173
44. Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Fruhbeck G (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92:3719–3727
45. Kiefer FW, Zeyda M, Todoric J, Huber J, Geyeregger R, Weichhart T, Aszmann O, Ludvik B, Silberhumer GR, Prager G, Stulnig TM (2008) Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149:1350–1357
46. Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31:504–507
47. Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188
48. Herder C, Carstensen M, Ouwens DM (2013) Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 15(Suppl 3):39–50